Related Experiment Video
Updated: May 26, 2026

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution
Published on: July 4, 2014
Dissolution studies and quantification of meloxicam in tablet dosage form by spectrophotometry
Madhusudhanareddy Induri1, Bhagavan Raju Mantripragada, Rajendra Prasad Yejella
1Department of Pharmaceutical Chemistry, Malla Reddy College of Pharmacy, Secunderabad, Andhra Pradesh, India. msreddyinduri@yahoo.com
Abstract:
Two simple and inexpensive UV spectrophotometric methods were developed for the quantification and dissolution studies of meloxicam in tablet dosage forms. Meloxicam was estimated at 365nm and 360nm in Method I and Method II, respectively. The calibration curve was linear over a concentration range from 2.0 to 12.0μg/ml for both methods. The limit of detection and limit of quantitation were found to be 0.12μg/ml and 0.38μg/ml, 0.09μg/ml and 0.27μg/ml for Method I and Method II, respectively. The percentage recoveries of meloxicam were found to be 99.68 to 100.61% and 99.11 to 100.96% for Method I and Method II, respectively. It was concluded that the developed methods are precise, accurate and were successfully applied for the estimation of meloxicam in pharmaceutical formulations and in vitro dissolution studies.
Related Concept Videos
Drug Dissolution: Requirements and Profile Comparison
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Spectrophotometry: Introduction
The essential components of a spectrophotometer include a source of electromagnetic radiation, a slot for placing a material to be analyzed, and a...
In Vitro Drug Dissolution: Alternative Methods
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
In Vitro Drug Dissolution: Compendial Testing Models II
